New York, NY · Founded 2020 · Privately Held (backing)
Operator of a gene therapy company intended to offer innovative clinical trials for the treatment of the rare monogenic disorder. Myrtelle is based in New York, NY and was founded in 2020. Its last reported valuation was $134 million in Dec 2022. It has raised $82.6 million across 4 recorded rounds; the latest was a $30.5 million early-stage round in Dec 2025.
Last reported valuation
$134.0M
Oct 2026
Priced at
—
Total raised
$82.6M
Last round
Early Stage VC
Dec 2025
Team — not yet on record
No current team members for Myrtelle are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Myrtelle with a free account
·Watch Myrtelle: the Monday email on marks, rounds and moves
